Molecular epidemiology, antimicrobial susceptibility, and toxin production of clinical Clostridioides difficile isolates from a teaching hospital in Northern China

Diagn Microbiol Infect Dis. 2023 Aug;106(4):115972. doi: 10.1016/j.diagmicrobio.2023.115972. Epub 2023 Apr 29.

Abstract

To grasp the epidemiological trend and drug resistance mechanisms of Clostridioides difficile (C. diff) in Beijing, 302 C. diff isolates were obtained from patients with diarrhea. The sequence types (STs) from mainstream strains were all susceptible to metronidazole, vancomycin, piperacillin/tazobactam, meropenem, and tigecycline but almost resistant to ciprofloxacin and clindamycin. The missense mutation of GyrA/GyrB and RpoB resulted in fluoroquinolone and rifamycin resistance, respectively. Toxigenic strains from clade IV were likely to be missed due to the deficiency of tcdA gene. Four tcdC genotypes were first detected in strains from clade III and IV. The truncating mutation of TcdC disabled its function working as a toxin suppressor. In conclusion, the molecular epidemiology of C. diff in Beijing is different from other regions of China. The antimicrobial resistance patterns and toxin-producing abilities of strains with different STs varied greatly, which suggests that continuous surveillance and control are meaningful and urgent.

Keywords: Beijing; Clostridioides difficile; Drug resistance; Molecular typing; Toxigenicity.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • China / epidemiology
  • Clostridioides / genetics
  • Clostridioides difficile*
  • Clostridium Infections* / epidemiology
  • Hospitals, Teaching
  • Humans
  • Microbial Sensitivity Tests
  • Molecular Epidemiology / methods

Substances

  • Anti-Bacterial Agents